This website uses cookies to enhance the user experience.
21st logo
||
V

VITALIS ASKER AS922 708 940

Process industry
Limited company
Drengsrudhagen 6 1385 ASKER, Norge

VITALIS ASKER AS

Operating
Produksjon av legemidler og farmasøytiske produkter.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

Chairman of the board
YZ

Yunlin Zhan1969

Years since formation
7 years
since May 6, 2019
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2025
-5,440
NOK
Total equity 2025
-497,709
NOK
Last update: Aug 3, 2026

Management

Board

NameRoleShares
YZ

Yunlin Zhan

1969

Chairman
90 %
indirectly

Top 10 individual shareholders

NameRoleShares
YZ

Yunlin Zhan

1969

Chairman
90 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
F
FJORDER & FJELL AS
Ordinary shares
100,000
100 %
Last update: Jun 2, 2025

Group structure

  • NORSUND GRUPPEN AS
    Total operating income 2024: NOK 641,134
    Operating profit 2024: NOK -523,842
    Employees: 0

Financials

in NOK

Summary

Year2025202420232022
Total operating income
0
0
0
0
Annual Total Result
-5,440
-8,529
-73,698
-68,252
Total assets
876,411
882,899
42,604
38,616
Total liabilities
1,374,121
1,380,608
1,379,628
1,301,943
Total equity
-497,709
-497,709
-1,337,024
-1,263,327

P&L

Year2025202420232022
Total operating income
0
0
0
0
Total operating costs
6,975
8,529
73,704
17,636
Operating result
-6,975
-8,529
-73,704
-17,636
Financial income/costs
0
0
6
-50,616
Profit before tax
-6,975
-8,529
-73,698
-68,252
Total tax & extraordinary income/cost
-1,535
0
0
0
Annual Total Result
-5,440
-8,529
-73,698
-68,252

Balance overview

Year2025202420232022
Total fixed assets
847,844
0
0
0
Total current assets
28,567
882,899
42,604
38,616
Total assets
876,411
882,899
42,604
38,616
Short term debt
0
-488
1,379,628
1,667
Long term debt
1,374,121
1,381,096
0
1,300,276
Total liabilities
1,374,121
1,380,608
1,379,628
1,301,943
Contributed capital
947,714
942,274
94,430
94,430
Retained earnings
-1,445,423
-1,439,983
-1,431,454
-1,357,757
Total equity
-497,709
-497,709
-1,337,024
-1,263,327
Total equity and liabilities
876,411
882,899
42,604
38,616

Classification

21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations